English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/62610
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Taking aim on bacterial pathogens: from phage therapy to enzybiotics

AuthorsHermoso, Juan A. ; García, José Luis ; García, Pedro
Issue DateOct-2007
PublisherElsevier
CitationCurrent Opinion in Microbiology, 10 (5) : 461-472 (2007)
AbstractThe bactericidal activity of bacteriophages has been used to treat human infections for years as an alternative or a complement to antibiotic therapy. Nowadays, endolysins (phage-encoded enzymes that break down bacterial peptidoglycan at the terminal stage of the phage reproduction cycle) have been used successfully to control antibiotic-resistant pathogenic bacteria in animal models. Their cell wall binding domains target the enzymes to their substrate, and their corresponding catalytic domains are able to cleave bonds in the peptidoglycan network. Recent research has not only revealed the surprising rich structural catalytic diversity of these murein hydrolases but has also yielded insights into their modular organization, their three-dimensional structures, and their mechanism of recognition of bacterial cell wall. These results allow endolysins to be considered as effective antimicrobials with potentially important applications in medicine and biotechnology
Description12 páginas, 3 figuras, 1 tabla -- PAGS nros. 461-472
Publisher version (URL)http://dx.doi.org/10.1016/j.mib.2007.08.002
URIhttp://hdl.handle.net/10261/62610
DOI10.1016/j.mib.2007.08.002
ISSN1369-5274
E-ISSN1879-0364
Appears in Collections:(CIB) Artículos
Files in This Item:
File Description SizeFormat 
restringido.pdf21,67 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.